Cory Maughan, DO
MOHS-Micrographic Surgery · Providence, UTNPI 1598086720
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $676 and has fallen 78.0% since, to $149 in 2025.
Across 90 payments — averaging $26.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$421
- Revance Therapeutics, Inc.$369
- Prugen, Inc. Pharmaceuticals$355
- AbbVie$301
- E.r. Squibb & Sons, L.L.C.$145
- Lilly USA, LLC$126
- plus $652 from 16 others
What the payments were for
- Food & beverage$2,29597%
- Education$733%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $421 |
| Revance Therapeutics, Inc. | 3 | $369 |
| Prugen, Inc. Pharmaceuticals | 2 | $355 |
| AbbVie(2 entities) | 16 | $301 |
| E.r. Squibb & Sons, L.L.C. | 6 | $145 |
| Lilly USA, LLC | 6 | $126 |
| Novartis | 7 | $116 |
| Sanofi | 7 | $114 |
| Galderma Laboratories, L.p. | 6 | $91 |
| VYNE Pharmaceuticals Inc. | 1 | $53 |
| Dermavant Sciences, Inc. | 3 | $47 |
| Amgen | 2 | $44 |
| Johnson & Johnson | 2 | $42 |
| Organogenesis Inc. | 2 | $31 |
| Medline Industries LP | 1 | $21 |
| UCB, Inc. | 1 | $18 |
| LEO Pharma Inc. | 1 | $18 |
| Merz North America, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Incyte Corporation | 1 | $12 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
| Organon | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAXXIFY$369
How this compares
Too few mohs-micrographic surgery providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $61,561 |
| Fluorouracil | 78 | $4,959 |
| Clobetasol Propionate | 62 | $1,674 |
| Mupirocin | 177 | $1,510 |
| Triamcinolone Acetonide | 64 | $1,067 |
| Cephalexin | 144 | $986 |
| Desoximetasone | 16 | $325 |
| Doxycycline Hyclate | 15 | $268 |
| Spironolactone | 13 | $264 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Providence
- Michael EyreSpanish Fork$9K
- Chad PetersonSpanish Fork$6K
- Breton YatesSalt Lake City$5K
- Keith DuffySalt Lake City$5K
- Jared HeatonBountiful$3K
- Sealtiel TinajeroRichfield$3K
- Emily PowellOgden$1K
- Jake FaganProvo$759
- John BlakeRoosevelt$723
- Jennifer StrunckSalt Lake City$697
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.